Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (6-((1e)-3-(methyl((3-methyl-1-benzofuran-2-yl)methyl)amino)-3-oxo-1-propen-1-yl)-2-oxo-3,4-dihydro-1,8-naphthyridin-1(2h)-yl)methyl Dihydrogen Phosphate
2. 2-propenamide, N-methyl-n-((3-methyl-2-benzofuranyl)methyl)-3-(5,6,7,8-tetrahydro-7-oxo-8-((phosphonooxy)methyl)-1,8-naphthyridin-3-yl)-, (2e)-
3. Afn-1720
4. Debio 1450
5. Debio1450
1. Afabicin [inn]
2. 1518800-35-5
3. Dmm8663h2r
4. [6-[(e)-3-[methyl-[(3-methyl-1-benzofuran-2-yl)methyl]amino]-3-oxoprop-1-enyl]-2-oxo-3,4-dihydro-1,8-naphthyridin-1-yl]methyl Dihydrogen Phosphate
5. (6-((1e)-3-(methyl((3-methyl-1-benzofuran-2-yl)methyl)amino)-3-oxoprop-1-en-1-yl)-2-oxo-3,4-dihydro-1,8-naphthyridin-1(2h)-yl)methyl Dihydrogen Phosphate
6. 2-propenamide, N-methyl-n-((3-methyl-2-benzofuranyl)methyl)-3-(5,6,7,8-tetrahydro-7-oxo-8-((phosphonooxy)methyl)-1,8-naphthyridin-3-yl)-, (2e)-
7. Debio1450
8. Debio 1450
9. Afabicin [who-dd]
10. Unii-dmm8663h2r
11. Chembl4297501
12. Schembl15479062
13. Schembl16262317
14. Gtpl10754
15. Db15268
16. Hy-109000
17. Cs-0030430
18. Q27276486
19. (6-((1e)-3-(methyl((3-methyl-1-benzofuran-2-yl)methyl)amino)-3-oxo-1-propen-1-yl)-2-oxo-3,4-dihydro-1,8-naphthyridin-1(2h)-yl)methyl Dihydrogen Phosphate
| Molecular Weight | 485.4 g/mol |
|---|---|
| Molecular Formula | C23H24N3O7P |
| XLogP3 | 1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 7 |
| Exact Mass | 485.13518711 g/mol |
| Monoisotopic Mass | 485.13518711 g/mol |
| Topological Polar Surface Area | 133 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 833 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
13
PharmaCompass offers a list of Afabicin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Afabicin manufacturer or Afabicin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Afabicin manufacturer or Afabicin supplier.
PharmaCompass also assists you with knowing the Afabicin API Price utilized in the formulation of products. Afabicin API Price is not always fixed or binding as the Afabicin Price is obtained through a variety of data sources. The Afabicin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Afabicin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Afabicin, including repackagers and relabelers. The FDA regulates Afabicin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Afabicin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Afabicin supplier is an individual or a company that provides Afabicin active pharmaceutical ingredient (API) or Afabicin finished formulations upon request. The Afabicin suppliers may include Afabicin API manufacturers, exporters, distributors and traders.
Afabicin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Afabicin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Afabicin GMP manufacturer or Afabicin GMP API supplier for your needs.
A Afabicin CoA (Certificate of Analysis) is a formal document that attests to Afabicin's compliance with Afabicin specifications and serves as a tool for batch-level quality control.
Afabicin CoA mostly includes findings from lab analyses of a specific batch. For each Afabicin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Afabicin may be tested according to a variety of international standards, such as European Pharmacopoeia (Afabicin EP), Afabicin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Afabicin USP).
